Central Precocious Puberty: Treatment with Triptorelin 11.25 mg

Background. Few data are available on quarterly 11.25 mg GnRH analog treatment in central precocious puberty (CPP). Aim. To assess the efficacy of triptorelin 11.25 mg in children with CPP. Patients. 17 patients (16 females) with CPP (7.9 ± 0.9 years) were treated with triptorelin 11.25 mg/90 days....

Descripción completa

Detalles Bibliográficos
Autores principales: Chiocca, Elena, Dati, Eleonora, Baroncelli, Giampiero I., Cassio, Alessandra, Wasniewska, Malgorzata, Galluzzi, Fiorella, Einaudi, Silvia, Cappa, Marco, Russo, Gianni, Bertelloni, Silvano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356708/
https://www.ncbi.nlm.nih.gov/pubmed/22645436
http://dx.doi.org/10.1100/2012/583751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356708/
https://www.ncbi.nlm.nih.gov/pubmed/22645436
http://dx.doi.org/10.1100/2012/583751

Ejemplares similares